preloader
Single Blog

CDSCO Moves to Stop Name Confusion From Holding up Device Imports.

The Central Drugs Standard Control Organization (CDSCO) has told its port offices to stop holding up the importation of medical devices on certain technical grounds.

Port officials should now allow the importation of products covered by valid certificates and licenses even if some of the details on the consignment differ from other records.

CDSCO sent out the memo after learning of three issues that are stopping medical devices and in vitro diagnostics from proceeding smoothly through ports. Some medical devices are being held up by slight differences between the names on consignments and on certificates and licenses. Other devices are getting stuck because the license holder is in the process of changing their details after a merger or acquisition. Finally, different expiry dates in multicomponent kits are causing delays.

Publication of the memo comes one month after the Drug Controller General of India (DCGI) told ports to stop detaining products covered by import licenses and registration certificates that are in the process of being renewed.

CDSCO Memo: http://www.cdsco.nic.in/writereaddata/OM%20Port%20Offices.pdf

Niranjan Andhalkar

https://prorelixresearch.com/mr-niranjan-andhalkar/

He is the Director – Director – Strategic Management & Planning at ProRelix Research. His visionary leader with 17+ years of experience in clinical research, pharmaceuticals, CROs, and healthcare IT. Known for driving business growth, strategic collaborations, and innovation, he has successfully built and scaled organizations in the global clinical research ecosystem. With academic expertise in Biotechnology, Clinical Research, and an MBA in Operations Management, he combines scientific knowledge with strong business strategy to create impactful and sustainable healthcare ventures.

Subscribe to our Newsletter

Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.

Loading
prorelix research

ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.